cytofluorometr
analysi
perform
character
immunophenotyp
lymphocyt
synovi
sf
peripher
blood
pb
patient
suffer
juvenjl
chronic
arthriti
aca
rheumatoid
arthriti
ra
obviou
differ
could
found
express
surfac
proteas
aminopeptidas
n
ap
wherea
monoclon
antibodi
specif
fail
reveal
surfac
express
lymphocyt
pb
sf
cell
gave
posit
stainin
g
use
correl
express
joint
diseas
could
found
patient
differ
type
inflammatori
joint
effus
express
cell
also
found
synovi
tissu
inflammatori
serou
caviti
effus
fixat
cell
reveal
presenc
intracellular
antigen
alreadi
locat
pb
cell
healthi
individu
induct
express
pb
cell
could
demonstr
incub
con
sf
patient
ra
find
suggest
role
ap
n
new
activationassoci
molecul
lymphocyt
abbrevi
sf
synovi
fluid
pe
peripher
blood
lca
juvenil
chronic
arthriti
rarheumatoid
arthriti
tatraumat
arthropathi
dddegen
joint
diseas
ap
n
aminopeptidas
n
dp
iv
dipeptidylpeptidas
iv
fitc
fluoresceinisothiocyan
pe
phycoerythrin
fc
fetal
calf
serum
although
recent
studi
fail
find
arthritisspecif
cell
phenotyp
pb
patient
vari
form
joint
diseas
synovi
lymphocyt
exhibit
number
peculiar
besid
heavi
preponder
cell
compos
almost
entir
cell
memori
phenotyp
express
known
discrep
increas
express
hladr
cell
synovi
cell
describ
express
specif
molecul
repres
function
abnorm
includ
reduc
respons
mitogen
lectin
compar
increas
respons
recal
antigen
order
character
function
state
sf
cell
compar
immunophenotyp
pb
sf
lymphocyt
pair
sampl
patient
either
ra
lca
particular
attent
paid
surfac
proteas
ap
dp
recent
year
interest
proteas
increas
remark
among
thing
peptidas
inhibitor
indic
role
ectopeptidas
regul
biolog
activ
peptid
cytokin
growth
factor
thu
great
number
studi
publish
respect
particip
constitut
express
transmembran
proteas
dp
iv
cell
activ
memori
howev
contradictori
result
publish
concern
occurr
ubiquit
zinccontain
exopeptidas
ap
n
lymphocyt
wherea
ap
nlike
enzymat
activ
detect
use
spectrophotometr
method
avail
monoclon
antibodi
recogn
monocyt
granulocyt
lymphocyt
pb
ap
n
catalyz
remov
peptid
ntermin
preferenti
neutral
amino
acid
residu
suggest
involv
metabol
regulatori
peptid
eg
small
intestin
renal
tubular
epitheli
cell
synapt
membran
use
twocolor
flow
cytometri
abl
detect
occurr
pb
sf
lymphocyt
surprisingli
sf
cell
pb
lymphocyt
show
vari
surfacelabel
differ
monoclon
antibodi
specif
subsequ
studi
immunophenotyp
sf
cell
patient
varieti
inflammatori
arthropathi
order
investig
possibl
correl
express
type
joint
diseas
addit
lymphocyt
synovectomi
tissu
spleen
serou
caviti
effus
studi
see
whether
display
surfac
express
incub
experi
sf
pb
lymphocyt
carri
obtain
first
insight
regul
lymphocyt
patient
differ
type
joint
effus
studi
diagnos
defin
clinician
suppli
sf
drawn
therapeut
reason
arthriti
patient
categor
four
clinic
group
jca
ra
traumat
arthropathi
ta
degen
joint
diseas
djd
patient
treat
nonsteroid
antiinflammatori
drug
andor
steroid
well
diseasemodifi
drug
sulfasalazin
none
patient
receiv
intraarticular
steroid
therapi
last
month
sampl
sf
ten
patient
ra
lca
pair
blood
sampl
collect
via
steril
heparin
tube
mnc
isol
ficollhypaqu
densiti
gradient
centrifug
bloodstain
sf
specimen
exclud
studi
cellfre
sf
store
blood
healthi
staff
member
laboratori
serv
control
group
synovi
tissu
obtain
patient
jca
undergo
synovectomi
mnc
elut
describ
abrahamsen
human
spleen
tissu
kindli
provid
hla
laboratori
medic
faculti
mnc
spleen
tissu
separ
use
ficollhypaqu
therapeut
procedur
periton
fluid
aspir
patient
suffer
ethanol
liver
cirrhosi
pericardi
fluid
obtain
ten
patient
undergo
heart
valv
replac
cell
collect
centrifug
use
doublelabel
two
wash
monoclon
antibodi
use
tal
coulter
krefeld
germani
immunotechdianova
hamburg
germani
becton
dickinson
heidelberg
germani
dako
hamburg
germani
immunotech
dianova
monoclon
antibodi
use
purchas
becton
dickinson
optim
dilut
use
flow
cytometri
establish
preliminari
experi
doublestain
mnc
perform
e
minut
two
cold
wash
pb
contain
sodium
azid
cell
fix
use
paraformaldehyd
comparison
differ
specif
monoclon
antibodi
indirect
immunofluoresc
stain
use
cell
incub
either
monoclon
antibodi
purifi
normal
mous
igg
two
wash
cell
label
peconjug
secondari
antibodi
wash
fix
mention
cytofluorometr
analys
perform
becton
dickinson
facscan
nonlymphoid
cell
dead
cell
exclud
set
appropri
forward
light
scatter
gate
cell
per
sampl
count
threshold
defin
manner
positivestain
includ
relev
neg
control
order
detect
intracellular
lymphocyt
cell
gentli
permeabil
follow
method
schmid
brief
block
nonspecif
bind
imin
preincub
human
ab
serum
cell
label
first
antibodi
two
wash
pellet
cell
fix
paraformaldehyd
solut
h
centrifug
pellet
cell
resuspend
tween
pb
room
temperatur
wash
centrifug
stain
intern
antigen
neg
controlp
follow
block
nonspecif
bind
human
ab
serum
two
wash
tween
pb
cell
could
analyz
aliquot
pb
mnc
x
cellsml
incub
variou
time
period
min
h
e
equal
amount
autolog
cellfre
sf
cell
wash
twice
pb
investig
presenc
cell
use
doublelabel
mnc
pb
healthi
subject
incub
concentr
x
cell
ml
rpm
contain
antibiot
lglutamin
fetal
calf
serum
fc
follow
condit
addit
b
con
ilgml
v
lml
c
sf
dilut
patient
ra
day
respect
lymphocyt
investig
surfac
molecul
case
cell
incub
presenc
cycloheximid
ilg
ml
data
express
mean
standard
deviat
student
ttest
pair
differ
use
compar
pair
sampl
blood
sf
n
case
statist
differ
analyz
use
ttest
unpair
data
welch
approxim
figur
compar
express
five
select
surfac
molecul
lymphocyt
patient
suffer
ra
lca
pair
sampl
sf
pb
found
signific
preponder
express
hladr
sf
versu
pb
cell
versu
versu
respect
alreadi
describ
sever
author
clear
differ
could
demonstr
case
express
versu
surprisingli
obviou
differ
surfac
molecul
express
sf
pb
found
pb
healthi
control
data
shown
neglig
amount
surfac
express
demonstr
cell
pb
patient
studi
contrast
sf
cell
use
monoclon
antibodi
express
allornon
phenomenon
instead
fluoresc
histogram
typic
rather
broad
fig
sf
cell
express
shown
figur
furthermor
slightlybut
significantli
decreas
express
exopeptidas
demonstr
sf
versu
pb
cell
versu
fig
use
peconjug
fitcconjug
fitcconjug
one
sampl
sf
cell
observ
stain
cell
ratio
found
obviou
differ
stain
compar
abovement
antibodi
nonconjug
form
use
indirect
method
peconjug
second
antibodi
data
shown
follow
experi
peconjug
use
unless
otherwis
indic
demonstr
investig
possibl
correl
type
arthriti
special
pattern
express
sf
cell
activ
molecul
doublestain
experi
perform
sf
figur
twocolor
immunofluoresc
analysi
sf
cell
repres
patient
jca
cell
differ
inflammatori
joint
effus
could
find
signific
differ
express
cell
surfac
molecul
studi
although
seem
increas
patient
highlyact
ca
tabl
answer
question
whether
occur
cell
exclus
within
sf
investig
immunophenotyp
lymphocyt
differ
sourc
cell
prepar
synovectomi
tissu
patient
ca
abl
demonstr
express
compar
sf
lymphocyt
cell
respect
next
spleen
tissu
kidney
donor
investig
express
lymphocyt
neglig
pb
cell
prepar
noninflammatori
periton
fluid
also
cdlr
contrast
cell
pericardi
fluid
ten
patient
undergo
heart
valv
replac
show
vari
level
express
cell
immunophenotyp
blast
cell
acut
myeloid
leukaemia
shown
antigen
may
detect
cytoplasm
myeloblast
membran
express
reason
tabl
interestingli
mani
pb
cell
healthi
person
stain
posit
fix
pb
lymphocyt
lca
patient
stain
result
need
investig
permeabil
sf
cell
also
exhibit
greater
amount
nativ
sf
cell
order
examin
effect
autolog
sf
immunophenotyp
pb
mnc
incub
mnc
pb
patient
lca
min
h
presenc
equal
amount
cellfre
sf
observ
neglig
stain
incub
lymphocyt
rang
min
h
cell
cdh
incub
result
distinct
express
pb
cell
cell
becam
taken
argument
express
occur
result
alter
surfac
lymphocyt
synovi
enzym
due
fact
sever
studi
describ
increas
aminopeptidas
activ
mitogen
stimul
lymphocyt
alreadi
exist
investig
express
cell
stimul
pb
mnc
control
subject
addit
cell
cultiv
sf
patient
ra
figur
reaction
furthermor
observ
tight
coexpress
surfac
molecul
studi
stimul
con
though
differ
cours
time
individu
hand
incub
mnc
sf
patient
ra
result
clear
increas
hladr
slight
decreas
addit
cycloheximid
sf
approxim
cell
stain
posit
fig
could
result
distribut
intern
storag
place
stain
fix
pb
lymphocyt
also
reveal
approxim
cell
tabl
possibl
conclus
follow
express
pb
lymphocyt
induc
mitogen
though
extent
reach
sf
regul
independ
cellfre
sf
contain
hladrbut
mediat
express
approxim
cell
need
pathway
may
inhibit
cycloheximid
effect
sf
pb
lymphocyt
uniformli
discuss
literatur
crout
report
addit
autolog
cellfre
sf
result
increas
incorpor
tritiat
thymidin
pb
lymphocyt
hand
hain
demonstr
sf
signific
stimulatori
effect
pb
lymphocyt
experi
necessari
obtain
clearer
pictur
influenc
cellfre
sf
lymphocyt
best
knowledg
paper
discuss
occurr
human
sf
lymphocyt
use
differ
monoclon
antibodi
specif
antigen
first
time
antibodi
could
detect
surfac
pb
lymphocyt
healthi
person
patient
ra
lca
permeabil
cell
reveal
presenc
intracellular
observ
confirm
result
enzymat
evid
ap
n
lymphocyt
seem
unlik
cell
acquir
surfac
aminopeptidas
consequ
migrat
process
tissu
compart
sinc
lymphocyt
prepar
spleen
tissu
show
detect
express
use
differ
monoclon
antibodi
addit
also
cell
periton
fluid
patient
ethanol
liver
cirrhosi
display
detect
stain
lean
toward
assumpt
cell
could
acquir
phenotyp
within
synovium
known
antibodi
subgroup
accord
abil
bind
least
differ
epitop
ap
n
glycoprotein
furthermor
suggest
least
five
subpopul
ap
n
exist
owe
differenti
util
glycosyl
site
subtl
differ
oligosaccharid
composit
rais
question
whether
unmask
alter
certain
epitop
synovi
enzym
reason
bind
monoclon
antibodi
sf
lymphocyt
seem
case
incub
pb
lymphocyt
patient
ra
autolog
sf
last
h
induc
subsequ
label
lymphocyt
specif
antibodi
furthermor
presenc
con
incub
pb
mnc
control
person
induc
increas
cell
activ
marker
hladr
also
fig
data
strongli
support
hypothesi
new
activationassoci
antigen
lymphocyt
result
literatur
concern
function
blood
cell
uniform
griffin
investig
myeloid
precursor
cell
specif
monoclon
antibodi
suggest
though
recogn
antibodi
could
express
low
antigendens
throughout
myeloid
differenti
detect
identifi
activ
prolifer
fraction
myeloid
coloni
form
cell
investig
monocyt
rheumatoid
synovi
tissu
macrophag
use
monoclon
antibodi
koch
observ
augment
monocyt
expos
interferongamma
lipopolysaccharid
antigen
increas
parallel
mhc
class
ii
antigen
express
also
monocyt
cultur
matur
macrophag
author
suggest
monocyt
enter
synovi
tissu
blood
rapidli
migrat
synovi
line
layer
bear
mhc
class
ii
activ
antigen
werfel
observ
variabl
enhanc
express
monocyt
granulocyt
within
minut
cell
stimul
though
exampl
simpli
transfer
situat
lymphocyt
show
complex
involv
activ
process
blood
cell
rare
occurr
lymphat
leukaemia
cellsinterpret
myeloic
coexpress
wors
prognosi
exampl
scarc
understood
integr
prolifer
differenti
process
addit
observ
repres
receptor
coronavirus
could
major
patholog
import
membran
proteas
cleav
n
termin
amino
acid
residu
small
polypeptid
ap
n
seem
suitabl
regul
biolog
activ
peptid
hormon
alreadi
shown
enkephalin
endorphin
degrad
ap
n
synapt
membran
central
nervou
system
case
enzym
accompani
anoth
zincdepend
membran
proteas
endopeptidas
calla
unabl
detect
differenti
antigen
lymphoid
precursor
cell
synovi
lymphocyt
data
shown
howev
major
cell
express
togeth
membran
proteas
express
activ
cell
irrespect
cell
cycl
result
make
tempt
specul
function
cooper
peptidas
summari
describ
occurr
new
activationassoci
molecul
synovi
cell
patient
differ
form
joint
effus
estim
cell
use
establish
diagnosi
patient
differ
form
arthriti
expect
howev
experi
prepar
investig
possibl
associ
inflammatori
activ
express
cell
sf
also
inflammatori
effus
fluid
